ADPT
Adaptive Biotechnologies Corp
27.90$
-2.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 40.8% | 35.3% | 26.2% | 22.9% | 31.9% | 31.3% | 44.4% | 40.3% | 25.8% | |
| 59.2% | 64.7% | 73.8% | 77.1% | 68.1% | 68.7% | 55.6% | 59.7% | 74.2% | |
| 83.2% | 70.3% | 83.1% | 118.0% | 92.2% | 76.5% | 71.7% | 57.5% | 33.9% | |
| 41.5% | 36.7% | 35.7% | 50.4% | 48.3% | 47.8% | 49.3% | 40.7% | 26.2% | |
| 172.7% | 154.1% | 166.0% | 232.4% | 203.4% | 176.8% | 189.0% | 150.6% | 94.9% | |
| -115.7% | -89.4% | -92.1% | -155.3% | -135.4% | -108.0% | -133.3% | -90.8% | -20.6% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 1.1% | 2.3% | 8.1% | 6.5% | 4.3% | |
| -111.4% | -83.4% | -80.6% | -148.6% | -134.3% | -108.1% | -132.3% | -89.2% | -21.5% | |
| -2.1% | 5.9% | -11.5% | -6.7% | -1.1% | -31.2% | 0.0% | – | – | |
| -111.4% | -83.4% | -80.6% | -148.6% | -134.3% | -108.0% | -132.3% | -89.1% | -21.5% | |
| -98.4% | -78.6% | -83.0% | -146.7% | -125.3% | -94.6% | -111.2% | -71.9% | -10.8% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.